Novo Nordisk said on Thursday it had filed a marketing application with the U.S. Food and Drug Administration for CagriSema, ...
Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week as it targets a fast-growing ...
Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug will sell at a massive discount there, compared ...
Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, pricing the lowest dose of 0 ...
Novo Nordisk said on Friday the European Medicines Agency's committee had issued a positive opinion for a higher dose of its ...
Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...
Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer health, nutrition and ...
Novo Nordisk cuts Wegovy price to $349 for cash payers early Novo launches $199 deal for Wegovy, Ozempic lowest doses GoodRx will launch a weight-loss telehealth service for $39 a month Nov 17 ...
Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results